Loading...
Rational identification of an optimal antibody mixture for targeting the epidermal growth factor receptor
The epidermal growth factor receptor (EGFR) is frequently dysregulated in human malignancies and a validated target for cancer therapy. Two monoclonal anti-EGFR antibodies (cetuximab and panitumumab) are approved for clinical use. However, the percentage of patients responding to treatment is low an...
Na minha lista:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Landes Bioscience
2011
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3242845/ https://ncbi.nlm.nih.gov/pubmed/22123060 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/mabs.3.6.17955 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|